Literature DB >> 7646903

Different detection rates of HER-2/NEU overexpression in ovarian carcinoma using two different commercially available detection kits.

H Romero, J Schneider.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7646903     DOI： 10.1016/0959-8049(95)00116-6

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN： 0959-8049            Impact factor:   9.162


× No keyword cloud information.
  3 in total

1.  Reporting recommendations for tumor marker prognostic studies (REMARK): explanation and elaboration.

Authors:  Douglas G Altman; Lisa M McShane; Willi Sauerbrei; Sheila E Taube
Journal:  BMC Med       Date:  2012-05-29       Impact factor: 8.775

2.  Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): explanation and elaboration.

Authors:  Douglas G Altman; Lisa M McShane; Willi Sauerbrei; Sheila E Taube
Journal:  PLoS Med       Date:  2012-05-29       Impact factor: 11.069

Review 3.  Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): An Abridged Explanation and Elaboration.

Authors:  Willi Sauerbrei; Sheila E Taube; Lisa M McShane; Margaret M Cavenagh; Douglas G Altman
Journal:  J Natl Cancer Inst       Date:  2018-08-01       Impact factor: 13.506
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.